The California Department of Public Health’s Genetic Disease Screening Program (GDSP) began screening for adrenoleukodystrophy in mid-September 2016.
Newborn Screening by State
Connecticut was the second state in the nation to implement a statewide screening program to test all newborns for adrenoleukodystrophy. The ALD test was implemented by the State Public Health Laboratory on July 1, 2016.
District of Columbia
The District of Columbia started newborn screening for ALD in September 2018.
On May 1, 2018, the Florida Department of Health, Newborn Screening Program began screening all newborns for adrenoleukodystrophy. This addition to the panel of disorders screened in Florida was recommended in 2016 by the Florida Genetics and Newborn Screening Advisory Council, and funding was authorized during the 2017 legislative session.
Georgia started screening for adrenoleukodystrophy on July 1, 2019.
Illinois started newborn screening for ALD in June 2019.
Kentucky started newborn screening for ALD on July 9, 2018.
Michigan started newborn screening for ALD in October 2019.
On June 15, 2016, thanks to tireless work by Shanna and Nick Quimby, the Minnesota Department of Health (MDH) added adrenoleukodystrophy to its list of conditions for which all newborns in the state are screened. That legislation is known as The Super Gav Act.
Nebraska started newborn screening for ALD in July 2018.
In 2013, New York became the first state in the United States to test all newborns for adrenoelukodystrophy. We are inspired by Elisa Seeger for her tireless advocacy, and we hope that Congress will pass “Aidan’s Law” requiring newborn screening for ALD in all 50 states.
Pennsylvania started newborn screening for ALD on April 2017.
Rhode Island started newborn screening for ALD on October 1, 2018.
On May 7, 2015, Kathy Switow, Elisa Seeger, and Jenny Weldon attended the Genetics Advisory Committee meeting in Tennessee. Kathy spoke about her son Blake and his journey with adrenoleukodystrophy and asked the committee to consider adding ALD to the newborn screening panel. Elisa spoke about her son Aidan and shared statistics from New York. Validation testing began in January 2018. It took three years, but the State of Tennessee Department of Health began screening for adrenoleukodystrophy on April 30, 2018.
The Newborn Screening program began screening for ALD on August 5, 2019.
The Ethan Zakes Foundation began working with the State Board of Health in 2013 to explore the possibility of adding adrenoleukodystrophy to Washington’s newborn screening panel. The Washington State Department of Health added ALD to the newborn screening panel on March 1, 2018.